Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Don't know why ---

Institutional investors don't buy on good news. They buy on results. To attract the big boys we need sustained earnings over multiple quarters. Also, very rarely do they invest substatial sums in BB stocks.

Share
New Message
Please login to post a reply